Clinical Trial Update: Steroid Treatment for Hypereosinophilic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update on steroid treatment for hypereosinophilic syndrome completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilia
• Hematologic Diseases
• Hypereosinophilic Syndrome
• Leukocyte Disorder

Drugs mentioned

• steroid treatment

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Eosinophilia, Hypereosinophilic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2022-02-15